Future Directions in the Treatment of Patients With HER2+ Breast Cancer: What Community Oncologists Need to Know
CLICK TO EDIT MASTER TITLE STYLE Business Intelligence and Reporting at SETMA: Improving Quality, Outcomes and Clinical Practices Dr. James L. Holly, MD.
Immuno-Oncology: An Evolving Approach to Cancer Care
The Future of Antiangiogenic Therapies in Ovarian Cancer: A Series of Community and Academic Grand Rounds
Research Ethics
Provider Payer Integration (Himss11 192)
Using Data to Enhance Skills for Learning, Living and Working in the 21 st Century An Australian Perspective Ralph Saubern Director, Professional Resources.
CReATE Presented by: Marcy Friedle, Grants Compliance Analyst.
Hit Hard, Hit Early: When to Treat and With What? Brian G. Gazzard, MD, Moderator Julio Montaner, MD Calvin J. Cohen, MD, MS.
Manish A. Shah, MD Director, Gastrointestinal Oncology Weill Cornell Medical College NewYork-Presbyterian Hospital New York, New York Treatment of HER2-Positive.
DISCLAIMER: The views and opinions expressed in this presentation are those of the author and do not necessarily represent official policy or position.
Information Communication Technologies (ICT) and Improved Agricultural Information Management System (AIMS), their applications in climate change mitigation.